Specifications Manual for Joint Commission National Quality Measures (v2023B)
Posted: 02/03/2023

Home » Comprehensive Cardiac Center-Outpatient (CCCOP)

Release Notes:
Measure Information Form
Version 2023B


Comprehensive Cardiac Center-Outpatient (CCCOP)

Set Measures

Set Measure ID Measure Short Name
CCCOP-01 Cardiac Rehabilitation Referral from an Outpatient Setting
CCCOP-02 Cardiac Rehabilitation Referral for Heart Failure Patients with Reduced Ejection Fraction from an Outpatient Setting
CCCOP-03 Cardiac Rehabilitation Enrollment from an Outpatient Setting

General Data Elements

Element Name Collected For
Birthdate All Records,
CPT® Code All Records,
Hispanic Ethnicity All Records,
ICD-10-CM Other Diagnosis Codes All Records, Optional for HBIPS-2, HBIPS-3
ICD-10-CM Principal Diagnosis Code All Records, Optional for HBIPS-2, HBIPS-3
ICD-10-PCS Other Procedure Codes All Records, Optional for All HBIPS Records
ICD-10-PCS Other Procedure Dates All Records, Optional for All HBIPS Records
ICD-10-PCS Principal Procedure Code All Records, Optional for All HBIPS Records
ICD-10-PCS Principal Procedure Date All Records, Optional for All HBIPS Records
Race All Records,
Sex All Records,

Measure Set Specific Data Elements

Element Name Collected For
CPT® Code Procedure Date CCCOP-01, CCCOP-03
Cardiac Rehabilitation Attendance CCCOP-03
Clinical Trial CCCOP-01, CCCOP-02
Comfort Measures Only CCCOP-01, CCCOP-02
Communication of Outpatient Referral to Patient CCCOP-01, CCCOP-02
Discharge Code CCCOP-01, CCCOP-02, CCCOP-03
E/M Code CCCOP-01, CCCOP-02, CCCOP-03
LVSD CCCOP-02
Outpatient Encounter Date CCCOP-01, CCCOP-02, CCCOP-03
Reason for No Cardiac Rehabilitation Enrollment CCCOP-03
Reason for No Referral to Outpatient Cardiac Rehabilitation Program CCCOP-01, CCCOP-02, CCCOP-03
Referral to Outpatient Cardiac Rehabilitation CCCOP-01, CCCOP-02, CCCOP-03
Site Identifier CCCOP


  Document Name  
Data Dictionary  

Comprehensive Cardiac Center (CCC) Initial Patient Population

Data collection for five new standardized performance measures are required for Comprehensive Cardiac Center (CCC) certification. In addition, a second set of optional measures are available. All currently certified CCC organizations, as well as those seeking initial certification, are required to implement data collection on the five mandatory standardized measures.

The measures chosen for implementation within the CCC certification program address major aspects of cardiac care, within the following 4 domains: cardiac rehabilitation, myocardial infarction (MI), heart failure (HF), and cardiac surgery (coronary artery bypass graft, cardiac valve repair/replacement and percutaneous coronary intervention [PCI]). The measures are separated into mandatory and optional measures and then again by inpatient and outpatient status. The certification program also includes 5 measures that are currently used in The Joint Commission’s Advanced Heart Failure Certification program (ACHF-01, ACHF-02, ACHF-06, ACHFOP-03, and ACHFOP-06). Organizations should follow the ACHF and ACHFOP initial patient population algorithm’s that are posted to The Joint Commission’s Measure Specifications Manual to determine the patient population for the heart failure measures.

There are 5 mandatory measures: high-intensity statin, aldosterone antagonist, beta-blockers, post-discharge appointment and post-discharge evaluation that all certified organizations must abstract. The additional 3 inpatient and 5 outpatient measures are optional. It is highly recommended that the all organizations collect the optional measures to assist them with advancing quality of care for the cardiac patients they serve.

All the mandatory measures capture the quality of care provided to myocardial infarction (MI) and heart failure patients. Organizations are required to submit inpatient cases for their heart failure patient population and observation and inpatient cases for their MI patient population for the mandatory measures. If the organization submits data for the optional inpatient measures, submitting observation cases is optional.

In order to assist organizations in determining their patient populations for performance measurement, The Joint Commission has defined outpatient, inpatient, and observation. Patients assigned as outpatients are defined as, a patient who is not hospitalized overnight but who visits a hospital, clinic, or associated facility for diagnosis or treatment. CPT® codes are utilized to bill outpatient cases when the patient undergoes a procedure. Any patient who has outpatient surgery that is billed using a CPT® code should be assigned to the outpatient bucket to determine cases for abstraction.

Patients assigned as inpatient or observation are defined as, a patient who is hospitalized overnight. ICD-10 PCS codes are utilized to bill inpatient and observation cases when the patient undergoes a procedure. Any patient who is listed as an inpatient

Comprehensive Cardiac Center (CCC) Outpatient Initial Patient Population
The population for this outpatient measure set is identified using the following 5 data elements:
  • Birthdate
  • EM Code
  • ICD-10-PCS Principal Diagnosis Code
  • Patients with an HCPCS/CPT® Procedure Code
  • Outpatient Encounter Date

Patients seen in the outpatient setting are included in the outpatient initial patient population if they have: Patient Age (Outpatient Encounter Date — Birthdate) ≥18 years old and an E/M Code on Appendix A, Table 2.0 for a hospital outpatient encounter.

AND

Subpopulation Medial - heart failure and myocardial infarction identified by:
  • ICD-10-CM Principal Diagnosis Code as defined in (HF) Appendix A, Table 2.1, or (MI) Appendix A, Table 2.3
Surgical -PCI, ICD identified by:
  • HCPCS/CPT® code defined in Appendix A, Table 2.11 (PCI)


Initial Patient Population Algorithm


CCC Sample Size Requirements

Hospitals that choose to sample have the option of sampling quarterly or monthly. A hospital may choose to use a larger sample size than is required. Hospitals whose patient population size is less than the minimum number of cases per quarter for the measure set cannot sample.

Regardless of the option used, hospital samples must be monitored to ensure that sampling procedures consistently produce statistically valid and useful data. Due to exclusions, hospitals selecting sample cases MUST submit AT LEAST the minimum required sample size.

Sample sizes are based on the hospital’s patient population for each measure category. Once the patient population for each measure category is determined the coinciding measures should be abstracted for the measure category population. An asterisk (*) after the listed measures denotes the mandatory standardized measures that certified organizations must abstract data for. The additional measures that are listed are optional.

Measure Category
Measures
Heart Failure
CCCIP-02*, ACHF-01*, ACHF-02*, ACHF-06*, CCCIP-04, CCCOP-02, ACHFOP-03, ACHFOP-06
MI
CCCIP-01*, CCCIP-03, CCCOP-01, CCCOP-03
PCI/CABG/Valve
CCCIP-03, CCCIP-05, CCCOP-01 (PCI only), CCCOP-03 (PCI only)

*Mandatory standardized measures that certified organizations must abstract.

Sampling is a process of selecting a representative part of a population to estimate the organization’s performance without collecting data for its entire population. Using a statistically valid sample, an organization can measure its performance in an effective and efficient manner. Sampling is a particularly useful technique for performance measures that require primary data collection from a source, such as the medical record. Sampling should not be used unless the organization has a large number of cases in the measure population, because a fairly large number of sample cases is needed to achieve a representative sample of the population of interest. To obtain statistically valid sample data, the sample size should be carefully determined and the sample cases should be randomly selected in such a way that the individual cases in the population have an equal chance of being selected. Only when the sample data truly represent the whole population can the sample-based performance measure data be meaningful and useful.

Sampling Approach:
  • Simple random sampling - selecting a sample size (n) from a population of size (N) in such a way that every case has the same chance of being selected. Systematic random sampling - selecting every kth record from a population of size N in such a way that a sample size of n is obtained, where k ≤ N/n. The first sample record (i.e., the starting point) must be randomly selected before taking every kth record. This is a two-step process: a) randomly select the starting point by choosing a number between one and k using a table of random numbers or a computer-generated random number; and b) then select every kth record thereafter until the selection of the sample size is completed.

The following sample size tables for each option automatically build in the number of cases needed to obtain the required sample sizes. For information concerning how to perform sampling, refer to the Population and Sampling Specifications section in this manual.

Quarterly Sampling Hospitals performing quarterly sampling for CCC must ensure that it has determined a patient population for each measure category listed below and that the sample size per measure category meets the following conditions:

Measure Category
Average Quarterly
Patient Population
Size "N"
Minimum Required
Sample Size "n"
Heart Failure ≥ 1516 304
381 - 1515 20% of Patient Population size
76-380 76
0 - 75 No sampling; 100% Patient Population required

Measure Category
Average Quarterly
Patient Population
Size "N"
Minimum Required
Sample Size "n"
MI ≥ 1516 304
381 - 1515 20% of Patient Population size
76-380 76
0 - 75 No sampling; 100% Patient Population required

Measure Category
Average Quarterly
Patient Population
Size "N"
Minimum Required
Sample Size "n"
PCI ≥ 1516 304
381 - 1515 20% of Patient Population size
76-380 76
0 - 75 No sampling; 100% Patient Population required

Measure Category
Average Quarterly
Patient Population
Size "N"
Minimum Required
Sample Size "n"
CABG ≥ 1516 304
381 - 1515 20% of Patient Population size
76-380 76
0 - 75 No sampling; 100% Patient Population required

Measure Category
Average Quarterly
Patient Population
Size "N"
Minimum Required
Sample Size "n"
Valve ≥ 1516 304
381 - 1515 20% of Patient Population size
76-380 76
0 - 75 No sampling; 100% Patient Population required

Monthly Sampling Hospitals performing monthly sampling for CCC must ensure that it has determined a patient population for each measure category listed below and that the sample size per measure category meets the following conditions:

Measure Category
Average Quarterly
Patient Population
Size "N"
Minimum Required
Sample Size "n"
Heart Failure ≥ 506 102
131 - 505 20% of Patient Population size
26-130 26
<26 No sampling; 100% Patient Population required

Measure Category
Average Quarterly
Patient Population
Size "N"
Minimum Required
Sample Size "n"
MI ≥ 506 102
131 - 505 20% of Patient Population size
26-130 26
<26 No sampling; 100% Patient Population required

Measure Category
Average Quarterly
Patient Population
Size "N"
Minimum Required
Sample Size "n"
PCI ≥ 506 102
131 - 505 20% of Patient Population size
26-130 26
<26 No sampling; 100% Patient Population required

Measure Category
Average Quarterly
Patient Population
Size "N"
Minimum Required
Sample Size "n"
CABG ≥ 506 102
131 - 505 20% of Patient Population size
26-130 26
<26 No sampling; 100% Patient Population required

Measure Category
Average Quarterly
Patient Population
Size "N"
Minimum Required
Sample Size "n"
Valve ≥ 506 102
131 - 505 20% of Patient Population size
26-130 26
<26 No sampling; 100% Patient Population required

Sample Size Examples
  • Quarterly sampling:
    • A hospital’s CCC patient population size per measure category, during the 2nd quarter, has been:
      • 2nd quarter patient populations
        • Heart Failure-650 patients
        • MI-345 patients
        • PCI-62 patients
        • CABG-80 patients
        • Valve-35 patients
      • The required sample size per measure category for the 2nd quarter, would be:
        • Heart Failure-130 patients (650 patients per quarter during the past quarter x 20%=130)
          • The hospital will abstract the following mandatory measures and if the organization chooses the additional optional measures for these 130 heart failure patients:
            • CCCIP-02 - mandatory
            • ACHF-01 - mandatory
            • ACHF-02 - mandatory
            • ACHF-06 - mandatory
            • CCCIP-04 -optional
            • CCCOP-02 - optional
            • ACHFOP-03 – optional
            • ACHFOP-06 - optional
        • MI-76 patients
          • The hospital will abstract the following mandatory measures and if the organization chooses the additional optional measures for these 76 MI patients:
            • CCCIP-01 - mandatory
            • CCCIP-03 - optional
            • CCCOP-01 - optional
            • CCCOP-03 - optional
        • PCI- 62 patients
          • No sampling, 100% of patient population required if the organization chooses to abstract the following optional measures:
            • CCCIP-03 - optional
            • CCCIP-05 - optional
            • CCCOP-01 - optional
            • CCCOP-03 - optional
        • CABG-76 patients
          • If the organization chooses, the following optional measures could be abstracted for these 76 CABG patients:
            • CCCIP-03 - optional
            • CCCIP-05 - optional
        • Valve-35 patients
          • No sampling, 100% of patient population required if the organization chooses to abstract the following optional measures:
            • CCCIP-03 - optional
            • CCCIP-05 - optional

  • Monthly sampling:
    • A hospital's CCC patient population size during the month of February, per measure category, has been:
      • February patient populations
        • Heart Failure-400 patients
        • MI-345 patients
        • PCI-80 patients
        • CABG-35 patients
        • Valve-20 patients
      • The required sample size, per measure category, for the February would be:
        • Heart Failure-80 patients (400 February patients x 20%=80)
          • The hospital will abstract the following mandatory measures and if the organization chooses, the additional optional measures for these 80 heart failure patients:
            • CCCIP-02 - mandatory
            • ACHF-01 - mandatory
            • ACHF-02 - mandatory
            • ACHF-06 - mandatory
            • CCCIP-04 -optional
            • CCCOP-02 - optional
            • ACHFOP-03 – optional
            • ACHFOP-06 - optional
        • MI-69 patients (345 February patients x 20%=69)
          • The hospital will abstract the following mandatory measures and if the organization chooses, the additional optional measures for these 69 MI patients:
            • CCCIP-01 - mandatory
            • CCCIP-03 - optional
            • CCCOP-01 - optional
            • CCCOP-03 - optional
        • PCI- 26 patients
          • If the organization chooses, the following optional measures could be abstracted for their 26 PCI patients:
            • CCCIP-03 - optional
            • CCCIP-05 - optional
            • CCCOP-01 - optional
            • CCCOP-03 - optional
        • CABG-26 patients
          • If the organization chooses, the following optional measures could be abstracted for their 26 PCI patients:
            • CCCIP-03 - optional
            • CCCIP-05 - optional
        • Valve-20 patients
          • No sampling, 100% of patient population required, if the organization chooses to abstract the following optional measures could be abstracted for all their valve patients:
            • CCCIP-03 - optional
            • CCCIP-05 - optional

Measure Information Form CCCOP
CPT® only copyright 2023 American Medical Association. All rights reserved.
Specifications Manual for Joint Commission National Quality Measures (v2023B)
Discharges 07-01-23 (3Q23) through 12-31-23 (4Q23)

LICENSE FOR USE OF CURRENT PROCEDURAL TERMINOLOGY, FOURTH EDITION (“CPT®”)

CPT® only copyright 2023 American Medical Association. All rights reserved. CPT® is a registered trademark of the American Medical Association.

You, your employees and agents are authorized to use CPT® only as contained in The Joint Commission performance measures solely for your own personal use in directly participating in healthcare programs administered by The Joint Commission. You acknowledge that the American Medical Association (“AMA”) holds all copyright, trademark and other rights in CPT®.

Any use not authorized herein is prohibited, including by way of illustration and not by way of limitation, making copies of CPT® for resale and/or license, transferring copies of CPT® to any party not bound by this Agreement, creating any modified or derivative work of CPT®, or making any commercial use of CPT®. License to use CPT® for any use not authorized herein must be obtained through the American Medical Association, Intellectual Property Services, AMA Plaza, 330 North Wabash Avenue, Suite 39300, Chicago, Illinois 60611-5885. Applications are available at the American Medical Association Web site, www.ama- assn.org/go/cpt.

U.S. Government Rights This product includes CPT® which is commercial technical data, which was developed exclusively at private expense by the American Medical Association, 330 North Wabash Avenue, Chicago, Illinois 60611. The American Medical Association does not agree to license CPT® to the Federal Government based on the license in FAR 52.227-14 (Data Rights - General) and DFARS 252.227-7015 (Technical Data - Commercial Items) or any other license provision. The American Medical Association reserves all rights to approve any license with any Federal agency.

Disclaimer of Warranties and Liabilities. CPT® is provided “as is” without warranty of any kind, either expressed or implied, including but not limited to the implied warranties of merchantability and fitness for a particular purpose. Fee schedules, relative value units, conversion factors and/or related components are not assigned by the AMA, are not part of CPT®, and the (AMA is not recommending their use. The AMA does not directly or indirectly practice medicine or dispense medical services. The responsibility for the content of this product is with The Joint Commission, and no endorsement by the AMA is intended or implied. The AMA disclaims responsibility for any consequences or liability attributable to or related to any use, non-use, or interpretation of information contained or not contained in this product.

This Agreement will terminate upon notice if you violate its terms. The AMA is a third party beneficiary to this Agreement.

Should the foregoing terms and conditions be acceptable to you, please indicate your agreement and acceptance by clicking below on the button labeled “accept”.

^